Study of Peripheral Mononuclear Cells and CD34 Levels as a Predictive Marker for Initiating Apheresis in Autologous Stem Cell Transplant

Background: Autologous HCT in multiple myeloma is done as upfront treatment in newly diagnosed transplant eligible patients after induction chemotherapy. In addition, it is standard for relapsed, aggressive non-Hodgkin lymphoma (NHL) and classical Hodgkin lymphoma (HL), and is curative in ~40% to 45...

Descripción completa

Detalles Bibliográficos
Autores principales: Pura Krishnamurthy, Kiran, Sarathy, Vinu, Jayappa, Sriniivas Belagutty, Badarkhe, Girish V, Kumar KS, Rajesh, Thianeshwaran, S, Byas, Nitin, Mufti, Suhail Sayeed, Varayathu, Hrishi, Naik, Radheshyam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748243/
https://www.ncbi.nlm.nih.gov/pubmed/35082998
http://dx.doi.org/10.18502/ijhoscr.v15i3.6847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748243/
https://www.ncbi.nlm.nih.gov/pubmed/35082998
http://dx.doi.org/10.18502/ijhoscr.v15i3.6847

Ejemplares similares